Onconetix, Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Emerging growth company
State of Incorporation
DE
Business Address
201 E. FIFTH STREET, CINCINNATI, OH, 45202
Mailing Address
201 E. FIFTH STREET, CINCINNATI, OH, 45202
Phone
513-620-4101
Fiscal Year End
1231
EIN
000000000
Financial Overview
FY2025
$18.57M
Total Liabilities
$-16.56
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| DEF 14A Definitive proxy statement | March 30, 2026 | View on SEC |
| 3 Initial insider ownership report | March 27, 2026 | View on SEC |
| 3 Initial insider ownership report | March 27, 2026 | View on SEC |
| 8-K Current report of material events | March 27, 2026 | View on SEC |
| 8-K/A Current report amendment | March 25, 2026 | View on SEC |
| 8-K Current report of material events | March 24, 2026 | View on SEC |
| 10-K Annual financial report | March 13, 2026 | View on SEC |
| 8-K Current report of material events | February 12, 2026 | View on SEC |
| 8-K Current report of material events | February 9, 2026 | View on SEC |
| DEF 14A Definitive proxy statement | January 2, 2026 | View on SEC |
Annual Reports
10-K
March 13, 2026
- Strategic pivot to focus on Proclarix, an advanced blood-based diagnostic test for prostate cancer, with EU approval and a U.S. partnership with LabCorp.
- Potential strategic diversification into the AI-powered digital health sector through a Share Exchange Agreement with Realbotix.
Material Events
8-K
Leadership Change
March 24, 2026
High Impact
- Appointment of David White as CEO to drive operational efficiency
- Strengthened board oversight with the addition of financial expert Sammy Dorf
8-K
Strategy Change
February 9, 2026
High Impact
- Shareholders approved a reverse stock split for Onconetix, Inc.
- The primary objective is to boost the stock price above $1.00 to meet Nasdaq listing requirements and avoid delisting.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.